![Disease Management Programs in the Medicaid Population](http://s1.studyres.com/store/data/008005181_1-4df22aa3bf43bcd753de022e1c55278a-300x300.png)
Disease Management Programs in the Medicaid Population
... hemoglobin HbA1c, and smoking status. They offered a modest payforoutcomes incentive for each risk factor improvement achieved. Additionally, on an eligible subset of these patients, they asked physicians to actively refer to population management programs those patients they determined could bene ...
... hemoglobin HbA1c, and smoking status. They offered a modest payforoutcomes incentive for each risk factor improvement achieved. Additionally, on an eligible subset of these patients, they asked physicians to actively refer to population management programs those patients they determined could bene ...
Making the Diagnosis of Asthma
... patients with chronic cough, asthma should always be considered as a possible diagnosis. The diagnostic and therapeutic approaches are similar to those for the typical form of asthma. The diagnosis of cough-variant asthma should be confirmed by the resolution of cough in response to asthma therapy. ...
... patients with chronic cough, asthma should always be considered as a possible diagnosis. The diagnostic and therapeutic approaches are similar to those for the typical form of asthma. The diagnosis of cough-variant asthma should be confirmed by the resolution of cough in response to asthma therapy. ...
Canadian Thoracic Society recommendations for management of
... hypertension is due to direct toxic effects of tobacco smoke on the pulmonary vasculature, resulting in the production of endothelial-derived vasoactive mediators and vascular remodelling. Changes seen are similar to those found in idiopathic pulmonary arterial hypertension (31,32). The presence of ...
... hypertension is due to direct toxic effects of tobacco smoke on the pulmonary vasculature, resulting in the production of endothelial-derived vasoactive mediators and vascular remodelling. Changes seen are similar to those found in idiopathic pulmonary arterial hypertension (31,32). The presence of ...
Bronchodilator tolerance: the impact of increasing bronchoconstriction J.M. Wraight , R.J. Hancox
... extent that recovery to baseline FEV1 could not be achieved after the methacholine challenge (30% fall) (fig. 3). Perhaps such patients are most at risk during acute severe asthma [21, 22]. While the cumulative dose of salbutamol (400 mg) used in this study appears to be small, it was administered v ...
... extent that recovery to baseline FEV1 could not be achieved after the methacholine challenge (30% fall) (fig. 3). Perhaps such patients are most at risk during acute severe asthma [21, 22]. While the cumulative dose of salbutamol (400 mg) used in this study appears to be small, it was administered v ...
White Paper Report on Excited Delirium Syndrome
... Despite increased research, the exact pathophysiology of ExDS remains unidentified. Some recent research in the area of fatal ExDS points to dopamine transporter abnormalities. Eventually, there might be found a genetic susceptibility, an enzyme excess or deficiency, an overdose or withdrawal state, ...
... Despite increased research, the exact pathophysiology of ExDS remains unidentified. Some recent research in the area of fatal ExDS points to dopamine transporter abnormalities. Eventually, there might be found a genetic susceptibility, an enzyme excess or deficiency, an overdose or withdrawal state, ...
A Diagnostic Approach to Pruritus
... Antihistamines are effective in treating histamine-mediated pruritus, but they may be less effective in patients with diseases that trigger pruritus through mechanisms involving serotonin, leukotrienes, or neuropeptides.1,2 Evaluation The initial clinical approach in patients with pruritus includes ...
... Antihistamines are effective in treating histamine-mediated pruritus, but they may be less effective in patients with diseases that trigger pruritus through mechanisms involving serotonin, leukotrienes, or neuropeptides.1,2 Evaluation The initial clinical approach in patients with pruritus includes ...
Ongoing Clinical Trials Posters II
... clinically eligible for IV rtPA treatment are randomised in the ratio of 1:1 into each arm. Primary endpoint is the proportion treated with rtPA. Secondary endpoints evaluate times to decision making, comparison of different image processing software and clinical outcomes at 3 months. Randomisation ...
... clinically eligible for IV rtPA treatment are randomised in the ratio of 1:1 into each arm. Primary endpoint is the proportion treated with rtPA. Secondary endpoints evaluate times to decision making, comparison of different image processing software and clinical outcomes at 3 months. Randomisation ...
AusPAR: Pomalidomide - Therapeutic Goods Administration
... For the treatment of MM in patients who have failed two or more prior therapies. The proposed indication is more restrictive, specifying the actual therapies that must be failed, and includes the use with low dose (LD) dexamethasone. At the time of the Australian submission to the TGA, three other r ...
... For the treatment of MM in patients who have failed two or more prior therapies. The proposed indication is more restrictive, specifying the actual therapies that must be failed, and includes the use with low dose (LD) dexamethasone. At the time of the Australian submission to the TGA, three other r ...
Concise Review
... Production of monoclonal protein by myeloma cells The characteristic property of myeloma cells is the production and secretion (release) of monoclonal protein into the blood and/or urine. The amount of monoclonal protein produced by myeloma cells varies considerably from patient to patient. In asses ...
... Production of monoclonal protein by myeloma cells The characteristic property of myeloma cells is the production and secretion (release) of monoclonal protein into the blood and/or urine. The amount of monoclonal protein produced by myeloma cells varies considerably from patient to patient. In asses ...
Vaccines
... when Prevnar was already available? Prevnar® (Pneumococcal 7-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) was the first pneumococcal conjugate vaccine (PCV) introduced to help protect infants and young children against invasive pneumococcal disease (IPD) and otitis media caused by seven str ...
... when Prevnar was already available? Prevnar® (Pneumococcal 7-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) was the first pneumococcal conjugate vaccine (PCV) introduced to help protect infants and young children against invasive pneumococcal disease (IPD) and otitis media caused by seven str ...
2. Early complications of Vascular Origin
... replication) have been reported as effective for cases of HC attributable to BK or adenovirus. c. If the above measures do not alleviate HC, other salvage approaches can be considered: selective embolisation of bladder arteries; catheterisation of both ureters to rest the bladder or;, as a last reso ...
... replication) have been reported as effective for cases of HC attributable to BK or adenovirus. c. If the above measures do not alleviate HC, other salvage approaches can be considered: selective embolisation of bladder arteries; catheterisation of both ureters to rest the bladder or;, as a last reso ...
Macular degeneration
... If your doctor thinks your eyesight could get worse quickly, they may suggest you try taking supplements containing beta-carotene, vitamin C, vitamin E, and zinc. These supplements may help to slow down the disease and the loss of sight, but only slightly. ...
... If your doctor thinks your eyesight could get worse quickly, they may suggest you try taking supplements containing beta-carotene, vitamin C, vitamin E, and zinc. These supplements may help to slow down the disease and the loss of sight, but only slightly. ...
Clinical Applications of Diffusion Imaging in the Spine
... The imaging assessment of the diffusion characteristics of water molecules on an intracellular and extracellular space level can herald powerful and information about normal and abnormal tissues and processes. Diffusion weighted imaging (DWI), a technique typically based on echo planar imaging (EPI ...
... The imaging assessment of the diffusion characteristics of water molecules on an intracellular and extracellular space level can herald powerful and information about normal and abnormal tissues and processes. Diffusion weighted imaging (DWI), a technique typically based on echo planar imaging (EPI ...
CURRICULUM VITAE - Vision Research Center
... Ibarra MS, Hsu J, Mirza N, Wu I-H, Ying GS, Mainster MA, Tolentino MJ. Retinal temperature increase during transpupillary thermotherapy: effects of pigmentation, subretinal blood, and choroidal blood flow. Invest Ophthalmol Vis Sci 2004; 45:3678-82. Hahn P, Lindsten T, Lyubarsky A, Ying GS, Pugh EN, ...
... Ibarra MS, Hsu J, Mirza N, Wu I-H, Ying GS, Mainster MA, Tolentino MJ. Retinal temperature increase during transpupillary thermotherapy: effects of pigmentation, subretinal blood, and choroidal blood flow. Invest Ophthalmol Vis Sci 2004; 45:3678-82. Hahn P, Lindsten T, Lyubarsky A, Ying GS, Pugh EN, ...
Fulminant hepatic failure in children
... Severe hepatitis in the context of disseminated fatal herpes simplex virus (HSV) infection has been reported rarely in infants, children and adults. Neonatal infection is usually severe, generalized and characteristically associated with retrograde spread of HSV-2 genital infection in the mother [19 ...
... Severe hepatitis in the context of disseminated fatal herpes simplex virus (HSV) infection has been reported rarely in infants, children and adults. Neonatal infection is usually severe, generalized and characteristically associated with retrograde spread of HSV-2 genital infection in the mother [19 ...
MediFocus Guidebook - The Morton Apfeldorf Parkinson`s Support
... • Section 3: Guide to the Medical Literature - This section opens the door to the latest cutting-edge research and clinical advances recently published in leading medical journals. It consists of an extensive, focused selection of journal article references with links to the PubMed® abstracts (summa ...
... • Section 3: Guide to the Medical Literature - This section opens the door to the latest cutting-edge research and clinical advances recently published in leading medical journals. It consists of an extensive, focused selection of journal article references with links to the PubMed® abstracts (summa ...
Payers SOF+Simeprevir
... Database Management, and Clinical Pathology • Implement a one-time electronic prompt for anti-HCV antibody testing for all patients born from 1945 through 1965 who have no record of HCV antibody testing • One-page educational tool for providers and one for patients (samples at KNOW MORE HEPATITIS/CD ...
... Database Management, and Clinical Pathology • Implement a one-time electronic prompt for anti-HCV antibody testing for all patients born from 1945 through 1965 who have no record of HCV antibody testing • One-page educational tool for providers and one for patients (samples at KNOW MORE HEPATITIS/CD ...
Evidence-Based Geriatric Medicine-2012-CD
... 65 years of age. Moreover, most countries including Canada, the United States and the United Kingdom have experienced a continuing increase in life expectancy, with an increase of approximately 1 year occurring every 5 years. These factors translate into a growing proportion of people aged 65 and ol ...
... 65 years of age. Moreover, most countries including Canada, the United States and the United Kingdom have experienced a continuing increase in life expectancy, with an increase of approximately 1 year occurring every 5 years. These factors translate into a growing proportion of people aged 65 and ol ...
Multiple sclerosis - Best of Health BMJ
... How do doctors diagnose multiple sclerosis? There isn't any simple test that says you have multiple sclerosis (MS). Because MS symptoms can come and go, it can take time to be sure you have the right diagnosis. MS is a serious disease. Doctors don't want to tell you that you have it if you don't, or ...
... How do doctors diagnose multiple sclerosis? There isn't any simple test that says you have multiple sclerosis (MS). Because MS symptoms can come and go, it can take time to be sure you have the right diagnosis. MS is a serious disease. Doctors don't want to tell you that you have it if you don't, or ...
Hyperuricemia and Gout: A review
... Uric acid is formed from the breakdown of purines 1. Increased uric acid production may be caused by various factors, including nutrition, hematologic and genetic factors. Other miscellaneous factors, such as obesity and excessive alcoholconsumption also increase urate production 1. While certain me ...
... Uric acid is formed from the breakdown of purines 1. Increased uric acid production may be caused by various factors, including nutrition, hematologic and genetic factors. Other miscellaneous factors, such as obesity and excessive alcoholconsumption also increase urate production 1. While certain me ...
... Objective: Megesterol acetate (MA) is a commonly used drug in the malnourished geriatric population to promote weight gain. Adrenal insufficiency is a well documented adverse effect of Megesterol acetate. We present a case with megesterol induced severe adrenal insufficiency presenting as mental ...
Leukemia - Alverno College Faculty
... Diagnosis for leukemia is done by specific blood tests, along with examining cells in the blood and bone marrow (Leukemia & Lymphoma society, 2006). ...
... Diagnosis for leukemia is done by specific blood tests, along with examining cells in the blood and bone marrow (Leukemia & Lymphoma society, 2006). ...
Product Information for Velcade - Therapeutic Goods Administration
... previously untreated multiple myeloma patients, has been assessed in two Phase III trials. A Phase III, randomised (1:1), open-label, multi-centre study conducted by the Italian Myeloma Network - GIMEMA, randomised 480 transplant-eligible patients under the age of 65 to receive three 3-week cycles o ...
... previously untreated multiple myeloma patients, has been assessed in two Phase III trials. A Phase III, randomised (1:1), open-label, multi-centre study conducted by the Italian Myeloma Network - GIMEMA, randomised 480 transplant-eligible patients under the age of 65 to receive three 3-week cycles o ...